Keyphrases
Disease Course
100%
Inflammatory Bowel Disease
100%
Infliximab
100%
Drug Dependence
100%
Dependent Patients
100%
Crohn's Disease
66%
Remission
66%
Corticosteroids
66%
Surgery Risk
66%
Mesalazine
66%
Low Risk
33%
Population-based Study
33%
Clinical Practice
33%
Adult Patients
33%
Frequent Use
33%
Response Pattern
33%
Drug Dosing
33%
Favorable Outcome
33%
Pediatric Patients
33%
Pediatric Research
33%
Non-responders
33%
Medical Therapy
33%
Mild Disease
33%
Drug Cessation
33%
Sustained Response
33%
Low Surgical Risk
33%
Dependent children
33%
Medicine and Dentistry
Disease Course
100%
Inflammatory Bowel Disease
100%
Infliximab
100%
Substance Use Disorder
100%
Crohn's Disease
66%
Mesalazine
66%
Combination Therapy
33%
Drug Withdrawal
33%
Pediatrics
33%
Surgical Risk
33%
Pediatrics Patient
33%
Patient with Inflammatory Bowel Disease
33%
Immunosuppressant
33%
Drug Dose Reduction
33%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Course
100%
Drug Dependence
100%
Infliximab
100%
Inflammatory Bowel Disease
100%
Remission
66%
Crohn's Disease
66%
Aminosalicylic Acid
66%
Combination Therapy
33%
Immunosuppressive Agent
33%